$21.87
1.72% yesterday
Nasdaq, May 20, 10:10 pm CET
ISIN
US74340E1038
Symbol
PGNY

Progyny Inc Stock price

$21.87
+0.50 2.34% 1M
+7.89 56.44% 6M
+4.62 26.78% YTD
-6.13 21.89% 1Y
-13.31 37.83% 3Y
-3.64 14.27% 5Y
+5.93 37.20% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.37 1.72%
ISIN
US74340E1038
Symbol
PGNY
Sector
Industry

Key metrics

Market capitalization $1.87b
Enterprise Value $1.65b
P/E (TTM) P/E ratio 38.60
EV/FCF (TTM) EV/FCF 8.41
EV/Sales (TTM) EV/Sales 1.36
P/S ratio (TTM) P/S ratio 1.55
P/B ratio (TTM) P/B ratio 4.01
Revenue growth (TTM) Revenue growth 9.47%
Revenue (TTM) Revenue $1.21b
EBIT (operating result TTM) EBIT $73.10m
Free Cash Flow (TTM) Free Cash Flow $195.78m
Cash position $256.12m
EPS (TTM) EPS $0.57
P/E forward 38.91
P/S forward 1.53
EV/Sales forward 1.35
Short interest 11.08%
Show more

Is Progyny Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Progyny Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Progyny Inc forecast:

4x Buy
40%
6x Hold
60%

Analyst Opinions

10 Analysts have issued a Progyny Inc forecast:

Buy
40%
Hold
60%

Financial data from Progyny Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,213 1,213
9% 9%
100%
- Direct Costs 946 946
9% 9%
78%
267 267
10% 10%
22%
- Selling and Administrative Expenses 190 190
9% 9%
16%
- Research and Development Expense - -
-
-
77 77
13% 13%
6%
- Depreciation and Amortization 3.57 3.57
45% 45%
0%
EBIT (Operating Income) EBIT 73 73
11% 11%
6%
Net Profit 53 53
14% 14%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Progyny Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Progyny Inc Stock News

Neutral
GlobeNewsWire
7 days ago
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicine's Regional Dean for Seattle and Puget Sound's Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow o...
Neutral
GlobeNewsWire
8 days ago
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / ...
Neutral
Seeking Alpha
12 days ago
Progyny, Inc. (NASDAQ:PGNY ) Q1 2025 Results Conference Call May 8, 2025 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Pete Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities David Larsen - BTIG Sarah James - Cantor Fitz...
More Progyny Inc News

Company Profile

Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Head office United States
CEO Peter Anevski
Employees 680
Founded 2008
Website www.progyny.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today